DEEPAK SETH: Open Payments
NPI 1154396711 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,344 in 167 payments from 29 companies in 2025. Trend: 2023 $1,467 · 2024 $2,005 · 2025 $3,344
Food & beverage: $3,344
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 21 | $426 |
| Novo Nordisk Inc | 18 | $357 |
| ABBVIE INC. | 18 | $235 |
| Vanda Pharmaceuticals Inc. | 9 | $225 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $210 |
| AstraZeneca Pharmaceuticals LP | 8 | $184 |
| Phathom Pharmaceuticals, Inc. | 3 | $172 |
| Lilly USA, LLC | 7 | $166 |
| Gilead Sciences, Inc. | 7 | $143 |
| Indivior Inc. | 7 | $143 |
Products named: HETLIOZ, Kerendia, ELIQUIS, NURTEC ODT, VOQUEZNA, BREZTRI, MOUNJARO, SUBLOCADE.
Industry payments across MD — which companies pay providers there.
